Biomarkers in the ICU: less is more? No

This publication has 16 references indexed in Scilit:

• Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms
  American Journal of Respiratory and Critical Care Medicine, 2018
• Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
  The Lancet Infectious Diseases, 2018
• International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
  European Respiratory Journal, 2017
• Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
  The Lancet Infectious Diseases, 2016
• Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
  Annals of Intensive Care, 2016
• Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response
  JAMA, 2015
• Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
  The Lancet Infectious Diseases, 2013
• Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient
  American Journal of Respiratory and Critical Care Medicine, 2012
• Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia
  American Journal of Respiratory and Critical Care Medicine, 2006
• C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study
  European Respiratory Journal, 2005